Clinical Trials Logo

Gastric Residual Volume clinical trials

View clinical trials related to Gastric Residual Volume.

Filter by:
  • None
  • Page 1

NCT ID: NCT05888090 Recruiting - Clinical trials for Gastric Residual Volume

The Effect of Position Given to Preterms After Feeding on Gastric Residual Volume, Abdominal Oxygenation and Fractional Oxygen Extraction

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

This study is a PhD dissertation. In this study, the investigators aim to investigate the effects of three different positions after feeding on gastric residual volume, abdominal oxygenation using near infrared spectroscopy (NIRS), and fractional oxygen extraction values in preterm newborns.

NCT ID: NCT05570292 Completed - Clinical trials for Gastric Residual Volume

Study of Effects of Preoperative Oral Domperidone on Gastric Residual Volume After Clear Fluid Ingestion in Patients Scheduled for Elective Surgeries

Start date: October 10, 2022
Phase: Phase 3
Study type: Interventional

General Anesthesia requires preoperative fasting according to specific instructions. Regarding Fasting Guidelines, The American Society of Anesthesiologists (ASA) recommends patients to fast from fatty food or meat eight hours prior to surgery, non-human milk or light meal for six hours prior, breast milk for four hours prior, and clear liquids including water, pulp-free juice, and tea without milk for two hours prior to the anesthetic. ASA fasting guidelines application represents the primary method to avoid aspiration as it ensures that stomach is empty before induction of anesthesia. These guidelines cannot be applied on all cases as in urgent or emergent situations or in morbidities associated with delayed gastric emptying, like Diabetes mellitus and some neurological disorders (

NCT ID: NCT05355428 Recruiting - Clinical trials for Gastric Residual Volume

Reducing Fasting Time for Breast Milk to 3 Hours

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to ascertain Gastric residual volume (GRV) of gastric contents in 35 infants who are breast fed 3 hours prior to general anaesthesia. The secondary aim of this study is to ascertain how well ultrasound (USS) derived measurement of GRV, using the gastric antrum cross sectional area (ACSA), correlates to direct measurement via aspiration.

NCT ID: NCT05106933 Completed - Clinical trials for Gastric Residual Volume

The Effect of Carbohydrate Loading 2 Hours Before Gastroscopy on Gastric Residual Volume and Patient's Well-being Score

Carborie
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

This is a single-blind randomized controlled trial with a stratified (diabetes mellitus, non-diabetes mellitus), balanced randomization (1:1), placebo-controlled study regarding the effect of carbohydrate loading 2 hours prior to the outpatient upper endoscopic procedure. All patients who were assigned for outpatient oesophagogastroduodenoscopy (OGDS) were invited to join in this study voluntarily from January 2021 until August 2021. This study was conducted in the Endoscopy Unit, Hospital Universiti Sains Malaysia, Kubang Kerian, Malaysia. The endoscopists that performed this procedure were blinded and there was trained staff who was not involved in the study to assess the well-being score. The study protocol had been approved by the Human Research Ethics Committee of Universiti Sains Malaysia (JEPeM) with the assigned protocol code USM/JEPeM/20080414.

NCT ID: NCT04682691 Completed - Clinical trials for Gastric Residual Volume

Effect of Metoclopramide Versus Erythromycin on on Gastric Residual Volume

Start date: March 1, 2021
Phase: Phase 4
Study type: Interventional

In emergencies, it may be necessary to anaesthetize who are not fully starved and consequently at risk of pulmonary aspiration. Pregnancy are recognized to be at increased risk of aspiration compared with non-pregnancy. Prokinetic agents such as metoclopramide can be used to reduce GRV. Metoclopramide is widely used as a prokinetic agent in adults and is licensed for premedication in pregnancy, but its use may be limited by its potential for producing extrapyramidal side effects. Erythromycin is an effective prokinetic agent in adults but there is no work examining its use for premedication in pregnancy. This study compared the effects of erythromycin and metoclopramide on GRV in full-term pregnant women

NCT ID: NCT04062851 Completed - Preterm Infant Clinical Trials

Routine Versus no Assessment of Gastric Residual Volumes in Preterm Infants

Start date: May 3, 2019
Phase: N/A
Study type: Interventional

The practice of checking gastric residuals is not evidence based. The amount of gastric residual volume (GRV) does not correlate with either feeding intolerance or development of NEC. We hypothesize that not monitoring GRV in infants with birth weights < 1,250 g, and who are being fed intermittently by gastric tube, will result in earlier attainment of full feeding. This is an unblinded randomized controlled trial where GRV will not be checked routinely in the intervention group.

NCT ID: NCT03952260 Completed - Clinical trials for Gastric Residual Volume

Feasibility of 1 Hour Clear Fluid Fasting Prior to Paediatric GA

Start date: May 15, 2019
Phase: N/A
Study type: Interventional

The study is aim to investigate the appropriate fasting time for clear fluid in paediatric patients who plan for elective minor surgery. This is a randomize control trial, which patient will be selected randomly to fast for clear fluid for 1 hour or 2 hours. It is important to determine the gastric residual volume for paediatric age group prior to elective minor surgery in order to determine whether the difference between 1 hour fasting and 2 hour fasting for clear fluid is significant.

NCT ID: NCT03948594 Not yet recruiting - Clinical trials for Gastric Residual Volume

The Effect of Carbohydrate Loading on Gastric Residual Volume and Hunger Score

Start date: May 2019
Phase: N/A
Study type: Interventional

This study conducted is to assess effect of carbohydrate loading (maltodextrin with whey protein) to gastric volume 2 hours after ingestion via aspiration while doing OGDS (direct visualisation) and patient's wellbeing (hunger, thirst, weakness, tiredness, anxiety) for all patient planned for OGDS. hypothesis H1: There is significant association between carbohydrate loading with residual gastric volume and subject's wellbeing H0: there is no significant association between carbohydrate loading with gastric residual volume and subject's wellbeing